Skin appendage disorders · 2025
Components of Severity in Alopecia Areata.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sanchez Katherine, Biba Ursula, Gregoire Samantha, Mesinkovska Natasha Atanaskova, Waldman Monique Margaret, Anderson Lisa, Mostaghimi Arash
Аннотация
INTRODUCTION: Severity of alopecia areata (AA) has been commonly defined by clinician assessment of scalp hair loss. Our aim was to characterize patient-reported factors beyond scalp hair loss that contribute to AA severity while modifying for socioeconomic factors.
METHODS: Patients with AA were recruited to take a survey. Multivariable linear regression was performed to evaluate lifetime AA severity while adjusting for socioeconomic variables, current AA severity at the time of survey, and patient-reported disease burden.
RESULTS: Patient-reported AA severity was associated with scalp hair loss (OR: 4.19, 95% CI: [1.35-13], p = 0.013), facial hair loss (OR: 3.55, 95% CI: [1.75-7.21], p < 0.001), increased financial burden (OR: 2.41, 95% CI: [1.21-4.8], p = 0.013), and greater emotional burden (OR: 2.96, 95% CI: [1.48-5.93], p = 0.002), while presence of comorbidities were linked to less severe AA (OR: 0.38, 95% CI: [0.17-0.84], p = 0.017).
CONCLUSION: Survey population was homogeneous and may not reflect the general community with AA. Self-reported data may introduce recency or recall bias. Scalp and facial hair loss, along with emotional and financial burdens, correlate with increased patient-reported AA severity. This suggests factors beyond scalp hair loss should be considered when assessing AA severity.
METHODS: Patients with AA were recruited to take a survey. Multivariable linear regression was performed to evaluate lifetime AA severity while adjusting for socioeconomic variables, current AA severity at the time of survey, and patient-reported disease burden.
RESULTS: Patient-reported AA severity was associated with scalp hair loss (OR: 4.19, 95% CI: [1.35-13], p = 0.013), facial hair loss (OR: 3.55, 95% CI: [1.75-7.21], p < 0.001), increased financial burden (OR: 2.41, 95% CI: [1.21-4.8], p = 0.013), and greater emotional burden (OR: 2.96, 95% CI: [1.48-5.93], p = 0.002), while presence of comorbidities were linked to less severe AA (OR: 0.38, 95% CI: [0.17-0.84], p = 0.017).
CONCLUSION: Survey population was homogeneous and may not reflect the general community with AA. Self-reported data may introduce recency or recall bias. Scalp and facial hair loss, along with emotional and financial burdens, correlate with increased patient-reported AA severity. This suggests factors beyond scalp hair loss should be considered when assessing AA severity.